Prevalence of Gram-negative Bacteria Isolated from Patients with Ventilator-Associated Pneumonia in Intensive Care Units of Imam Khomeini Hospital, Ahwaz, Iran
Background: Ventilator-associated pneumonia (VAP) is a common nosocomial infection among hospitalized patients who have undergone intubation and mechanical ventilation for more than 48 hours. Patients admitted to the intensive care unit (ICU) are at risk of developing life-threatening VAP due to specific conditions, especially with Gram-negative pathogens with advanced drug resistance. Hereby, the control of these agents and its monitoring is of particular importance. In this study, the pattern of antibiotic resistance of Gram-negative bacteria isolated from tracheal culture of patients with VAP investigated in ICU of Imam Khomeini Hospital of Ahwaz.
Materials and Methods: In this cross-sectional study, tracheal samples were collected during April 2016 to April 2017 from patients who were on mechanical ventilation in ICU of Imam Khomeini Hospital in Ahwaz, Khuzestan province, southwest of Iran. After isolation, bacterial strains were identified using biochemical tests. Then, antimicrobial resistance pattern of these isolates investigated using standard disc diffusion according to clinical and laboratory standards institute 2016 (CLSI 2016) guidelines.
Results: A total of 111 bacterial isolates were identified which were as following; Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Stenotrophomonas maltophilia, and Serratia marcescens, with prevalence of 54%, 19.8%, 14.4%, 6.4%, 4.5%, and 0.9%, respectively. Antibiotic susceptibility test of isolates showed that almost all isolates had high resistance to treatment antibiotics and were multi-drug resistance (MDR). The A. baumannii isolates were resistant to ciprofloxacin and piperacillin-tazobactam, but ampicillin-tazobactam had a good effect.
Conclusion: The results of this study showed that patients admitted to ICU due to their conditions of treatment are more likely to develop VAP by Gram-negative pathogens. The empirical treatment of VAP due to predominant bacterial causes and emerging drug resistance has become more challenging. It requires to use of multidrug regimens for routine clinical practice. It should be noted that in order to appropriate antimicrobial therapy, precise and correct diagnosis is very important.
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. American journal of respiratory and critical care medicine. Feb 15 2005;171(4):388-416.
Chastre J, Fagon JY. Ventilator-associated pneumonia. American journal of respiratory and critical care medicine. 2002;165(7):867-903.
Rea-Neto A, Youssef NCM, Tuche F. Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Critical care. 2008;12(2):R56.
Lachiewicz AM, Weber DJ, van Duin D, et al. From VAP to VAE: Implications of the New CDC Definitions on a Burn Intensive Care Unit Population. Infection control and hospital epidemiology. 2017;38(7):867-9.
Morehead RS, Pinto SJ. Ventilator-associated pneumonia. Arch Intern Med. 2000;160(13):1926-36.
Klompas M. Does this patient have ventilator-associated pneumonia? Jama. 2007;297(14):1583-93.
Baltimore RS. The difficulty of diagnosing ventilator-associated pneumonia. Pediatrics. 2003;112(6 Pt 1):1420-1.
Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2010;51 Suppl 1:81-7.
Salehi B, Goudarzi H, Nikmanesh B, Houri H, Alavi-Moghaddam M, Ghalavand Z. Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran. Journal of Infection and Chemotherapy; 2018.
Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005;128(6):3854-62.
Tille P. Bailey & Scott's Diagnostic Microbiology-E-Book: Elsevier Health Sciences; 2015.
Clinical and Laboratory Standards Institute PsfasteisCdM-W, PA: Clinical and Laboratory Standards Institute, 2016.
Society AT, America IDSo. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. American journal of respiratory and critical care medicine. 2005;171(4):388.
Luna CM, Aruj P, Niederman MS, et al. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. The European respiratory journal. 2006;27(1):158-64.
Djordjevic ZM, Folic MM, Jankovic SM. Distribution and antibiotic susceptibility of pathogens isolated from adults with hospital-acquired and ventilator-associated pneumonia in intensive care unit. Journal of infection and public health. 2017;10(6):740-744.
Koenig SM, Truwit JD. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clinical microbiology reviews. 2006;19(4):637-57.
Lahoorpour F, Delpisheh A, Afkhamzadeh A. Risk factors for acquisition of ventilator-associated pneumonia in adult intensive care units. Pakistan journal of medical sciences. 2013;29(5):1105.
Park SY, Lee HB. Prevention and Management of Ventilator-Associated Pneumonia. Korean Journal of Medicine. 2014;86(5):537-45.
Grgurich PE, Hudcova J, Lei Y, Sarwar A, Craven DE. Diagnosis of ventilator-associated pneumonia: controversies and working toward a gold standard. Current opinion in infectious diseases. 2013;26(2):140-50.
Hashemian SMR, Tabarsi P, Mohammad MM, et al. A prospective study of antibiotic susceptibility in patients with ventilator associated pneumonia. Anaesth Pain & Intensive Care. 2012;16(1):31-7.
Fujitani S, Sun H-Y, Victor LY, Weingarten JA. Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source. Chest. 2011;139(4):909-19.
Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clinical infectious diseases. 2002;34(5):634-40.
Zilberberg MD, Shorr AF. Prevalence of multidrug‐resistant pseudomonas aeruginosa and carbapenem‐resistant enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009. Journal of hospital medicine. 2013;8(10):559-63.
Paramythiotou E, Routsi C. Association between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patients. World Journal of Critical Care Medicine. 05/0410/03/received12/30/revised03/07/accepted 2016;5(2):111-120.
Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clinical Infectious Diseases. 2010;51(Supplement_1):81-7.
Charles MP, Easow JM, Joseph NM, Ravishankar M, Kumar S, Sivaraman U. Aetiological agents of ventilator-associated pneumonia and its resistance pattern - a threat for treatment. The Australasian medical journal. 2013;6(9):430-4.
Kazemi H, Yadegarynia D, Roodsari SR, Arab-Mazar Z. Evaluation of Antimicrobial Susceptibility Among Acintobacter baumannii by E-Test Method at Khatam-Al-Anbia Hospital During 2013-2015. Zahedan Journal of Research in Medical Sciences. 2017;19(1).
Yadegarynia D, Karimi J, Rahmati Roodsari S, Arab-Mazar Z. Evaluation of the antimicrobial resistance of Klebsiella pneumoniae by E-Test method in Khatam_ol_Anbia Hospital, Tehran, Iran, during 2015. Infection, Epidemiology and Microbiology. 2017;3(1):9-11.
Arabi Y, Al-Shirawi N, Memish Z, Anzueto A. Ventilator-associated pneumonia in adults in developing countries: a systematic review. International Journal of Infectious Diseases. 2008;12(5):505-12.